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Abstract
We conducted a systematic review of the Medline database (U.S. National Library of Medicine, National Institutes of Health,
Bethesda, MD, U.S.A) to determine if consistent molecular vaginal microbiota (VMB) composition patterns can be discerned
after a decade of molecular testing, and to evaluate demographic, behavioral and clinical determinants of VMB
compositions. Studies were eligible when published between 1 January 2008 and 15 November 2013, and if at least one
molecular technique (sequencing, PCR, DNA fingerprinting, or DNA hybridization) was used to characterize the VMB. Sixty
three eligible studies were identified. These studies have now conclusively shown that lactobacilli-dominated VMB are
associated with a healthy vaginal micro-environment and that bacterial vaginosis (BV) is best described as a polybacterial
dysbiosis. The extent of dysbiosis correlates well with Nugent score and vaginal pH but not with the other Amsel criteria.
Lactobacillus crispatus is more beneficial than L. iners. Longitudinal studies have shown that a L. crispatus-dominated VMB is
more likely to shift to a L. iners-dominated or mixed lactobacilli VMB than to full dysbiosis. Data on VMB determinants are
scarce and inconsistent, but dysbiosis is consistently associated with HIV, human papillomavirus (HPV), and Trichomonas
vaginalis infection. In contrast, vaginal colonization with Candida spp. is more common in women with a lactobacilli-
dominated VMB than in women with dysbiosis. Cervicovaginal mucosal immune responses to molecular VMB compositions
have not yet been properly characterized. Molecular techniques have now become more affordable, and we make a case for
incorporating them into larger epidemiological studies to address knowledge gaps in etiology and pathogenesis of
dysbiosis, associations of different dysbiotic states with clinical outcomes, and to evaluate interventions aimed at restoring
and maintaining a lactobacilli-dominated VMB.
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Introduction
It has been known for some time that most vaginal microbiota
(VMB) consist predominantly of lactobacilli and that VMB
alterations can cause symptomatic conditions [1]. The most
familiar condition is bacterial vaginosis (BV), which has tradition-
ally been characterized as a reduction of vaginal lactobacilli and
an overgrowth of other (facultative) anaerobic bacteria. In clinical
settings, BV is typically diagnosed using Amsel criteria (three of the
following four criteria should be present: 1) clue cells on wet mount
microscopy; 2) a ‘fishy’ odour after adding 10% KOH to vaginal
secretions; 3) vaginal pH.4.5; and 4) thin, homogenous vaginal
discharge) [2]. In research settings, BV is also often defined by
Gram stain Nugent scoring, which is based on microscopic
visualization of three bacterial morphotypes (a Nugent score of 0–
3 is considered normal, 4–6 intermediate microbiota, and 7–10
BV) [3]. BV is not highly inflammatory and is therefore often
asymptomatic; this is why it is referred to as a vaginosis and not a
vaginitis [1]. Two common types of microbiological vaginitis are
vaginal candidiasis and trichomoniasis [1]. Vaginal candidiasis is
often highly inflammatory and is typically diagnosed by wet mount
microscopy and/or culture of Candida species. Trichomoniasis is
caused by the sexually transmitted single-celled parasite Tricho-
monas vaginalis, which can be detected by microscopy, culture or
PCR.
Other types of vaginitis have been described (such as aerobic
vaginitis, desquamative inflammatory vaginitis, and atrophic
vaginitis) but occur less frequently [4–6]. The term ‘aerobic
vaginitis’ is used by some clinicians to refer to vaginal inflamma-
tion believed to be caused by streptococci, staphylococci and
Escherichia coli [4]. While the roles of vaginal Streptococcus
agalactiae (also known as Group B streptococcus) and E. coli in
invasive maternal and neonatal infections have been well-
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documented [7], their potential roles in causing a vaginitis
syndrome distinct from BV is not universally accepted.
Altered communities of micro-organisms in the vagina are not
only implicated in septic postpartum and neonatal infections but
also in pelvic inflammatory disease [8], miscarriage and pre-term
birth [9], and increased HIV acquisition and onward transmission
[10–12]. VMB alterations may therefore be of much greater
public health importance than was previously assumed.
In the last decade, phylogenetic analyses of vaginal samples
(mostly bacterial 16S ribosomal RNA gene sequencing) have
shown that bacterial communities in the vagina are more complex
than previously thought. The first study using molecular methods
to characterize the VMB was published in 2002 [13]. In a review
of studies conducted between 2002 and 2008, Srinivasan and
colleagues concluded that BV is indeed associated with a loss of
lactobacilli and the introduction and/or overgrowth of other
(facultative) anaerobic bacteria, and identified important VMB
bacteria that had previously been missed by culture-based
methods [14]. These bacteria included species in the Lactobacillus
genus (e.g. L. iners) and bacteria associated with BV (e.g.
Atopobium vaginae and three bacteria in the Lachnospiraceae
family temporarily named BVAB1, 2 and 3) [13,15,16].
Since 2008, high throughput molecular techniques have
become more affordable and accessible, and many more VMB
characterization studies have been performed. We conducted a
systematic review of the published literature from 2008 to date, to
synthesize current knowledge about the VMB and its determi-
nants, and to identify research gaps.
Methods
We conducted a systematic review according to the PRISMA
2009 guidelines [17].
Our first objective was to determine if any consistent VMB
composition patterns can be discerned after a decade of molecular
testing, despite the fact that different groups have used different
molecular techniques and/or operating procedures. Our second
objective was to review correlations between molecular composi-
tions, Amsel criteria, and Nugent scoring. Our third objective was
to assess which determinants (sociodemographic, physiological,
and behavioral risk factors, and the presence of pathogens in the
genital tract) have been consistently associated with certain VMB
composition patterns in different studies.
Search strategy and selection criteria
Eligible studies included studies that used at least one molecular
technique (sequencing, PCR, DNA fingerprinting, or DNA
hybridization). We only included PCR and DNA hybridization
studies if multiple bacterial species or genera were assessed (either
by multiple individual assays or by multiplex assays). We excluded
studies that focused on viral, archaeal, fungal, or protozoal
diversity, or on development of diagnostic assays. We only
considered randomized controlled intervention trials if the baseline
data, prior to the intervention, could be used to address one of our
objectives. Article selection was based on the first objective; not all
articles also addressed the second and third objectives.
We searched the Medline database (U.S. National Library of
Medicine, National Institutes of Health, Bethesda, MD, U.S.A.)
for articles between 1 January 2008 and 15 November 2013,
limiting our search to articles written in English. We started our
review in 2008 as opposed to 2002 (when the first molecular VMB
data were published) because Srinivasan and Fredricks published a
review of the early studies in 2008 [14]. We searched titles and
abstracts using the search term ‘vaginal micr*’. Two authors
(JvdW and HB) assessed the articles for eligibility, and hand-
searched the reference lists of eligible articles to identify additional
articles. Five authors (JvdW, HB, RV, VJ, and TC) extracted data
from all eligible articles using predefined data extraction tables,
which included the data categories presented in tables 1 and 2, a
description of the VMB compositions and correlates that the study
had identified, and study strengths and weaknesses. Each article
was reviewed independently by two authors.
Results
Study selection
Our Medline database search yielded 475 results, of which 50
were eligible. We identified 20 additional eligible articles from the
reference lists of the initial 50 articles. After data extraction, a
further seven articles were rejected because they did not address
our objectives appropriately (mostly because they focused on
technical laboratory issues or diagnostic assay development). A
total of 63 articles are therefore included in this review [18–80].
Study characteristics
Table 1 shows characteristics of the 63 articles (references are
included in the table and are not repeated here). It should be noted
that one article could include data from more than one data
extraction category, which is why some column totals exceed 63.
Most of the articles reported data from North America (31
articles), followed by Europe (13), Africa (10), Asia (9), and Central
America (3). Most sample sizes were small, with only 19 articles
reporting a sample size larger than 100. Most of the study
populations were non-pregnant adult women of reproductive age,
with or without BV as the only diagnosed condition (28 articles).
Other study populations included adolescents/virgins (3 articles),
pregnant women (7), postmenopausal women (5), women attend-
ing a sexual health clinic (7) or with confirmed HIV, HPV or other
infections (16), female sex workers (2), women who have sex with
women (WSW; 3), and women undergoing in-vitro fertilization
(IVF) (2). Sequencing was the most commonly employed
molecular technique; earlier studies tended to sequence DNA
isolated from individual colonies obtained by bacterial culture (15
articles), whereas later studies extracted DNA directly from genital
samples followed by next generation sequencing (18 studies used
454 sequencing (454 Life Sciences Corporation, Branford, CT,
US) and four used other platforms). PCR was also commonly used
with 19 studies using quantitative PCR (qPCR) for individual
species/genera, and four studies using qualitative multiplex PCR.
Other molecular techniques included DNA fingerprinting tech-
niques (13), phylogenetic DNA microarrays (4), and hybridization
to oligonucleotide probes coupled to beads (1). One of the main
aims in all articles was to describe the VMB in a particular study
population, and 20 articles included longitudinal data (indicated in
Table 1 as longitudinal VMB changes); three articles also
described cervical and/or endometrial microbiota and three rectal
and/or oral reservoirs of vaginal bacteria; and 17 employed a
clustering technique to characterize bacterial communities.
Definitions used for a healthy VMB and for BV
Most of the 63 articles that we reviewed used a Nugent score of
0–3 to define a healthy VMB (26 articles), with an additional 12
using a Nugent score of 0–3 plus the presence of fewer than three
Amsel criteria, and nine using a Nugent score of 0–6. Fourteen
articles did not provide a definition, and the remaining 27 articles
used a variety of definitions based on microscopy, vaginal pH, and
clinical symptoms. In the 37 articles that described a comparison
between a healthy VMB and BV, BV was mostly defined as a
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Table 1. Characteristics of molecular vaginal microbiota articles published between 1 January 2008 and 15 November 2013.
Number of
articles References
Year of 2008 6 18–23
publication 2009 11 24–34
2010 7 35–41
2011 13 42–54
2012 14 55–68
20131 12 69–80
TOTAL 63
Country2 USA & Canada 31 19–21, 23–25, 27, 28, 30–32, 35–39, 42, 44, 49, 59–61, 64–70, 77, 78
Belgium 6 26, 33, 34, 54, 62, 63
Europe – other3 7 18, 22, 43, 55, 72, 76, 79
China 6 29, 41, 47, 57, 74, 80
Asia – other4 3 35, 50, 71
South Africa 4 45, 46, 53, 73
East Africa5 4 25, 40, 48, 77
West Africa6 2 51, 58
Central America7 3 52, 56, 75
TOTAL 66
Sample size #10 4 28, 29, 56, 70
(women) 11–50 22 18–20, 22, 23, 25–27, 31, 36–38, 43, 44, 48–50, 54, 59, 61, 69, 73
51–100 18 24, 30, 33, 41, 45–47, 52, 55, 57, 58, 62, 63, 65, 66, 74, 78, 80
101–200 14 21, 32, 34, 35, 39, 40, 53, 67, 68, 71, 75–77, 79
.2008 5 42, 51, 60, 64, 72
TOTAL 63
Study
population
Adults, healthy or with BV 28 19, 22, 23, 26, 28, 29, 35, 36, 38, 41–43, 50, 54, 57, 59, 60, 62–64, 67, 68, 70, 72, 73,
75, 79, 80
Adolescents/virgins 3 24, 25, 66
Pregnant women 7 33, 34, 52, 55, 58, 68, 78
Postmenopausal women 5 43, 49, 55, 57, 71
STD clinic attendees 7 19, 37, 38, 60, 62, 65, 76
Female sex workers 2 25, 48
WSW 3 21, 39, 61
By HIV status 11 20, 30, 40, 44–46, 48, 51, 53, 58, 77
By HPV/cytology status 5 46, 56, 66, 71, 74
Women undergoing IVF 2 18, 69
TOTAL 78 TOTAL
Molecular
technique2
NGS sequencing 4549 18 20, 36, 41, 42, 44, 48, 56, 58–60, 64, 65, 67, 68, 70–72, 76
NGS sequencing other9 4 40, 49, 56, 67
Culture & sequencing 15 18, 19, 23, 28, 29, 35, 50, 53, 54, 56, 57, 69, 73, 75, 78
qPCR 19 21, 26, 30, 37–39, 41, 42, 47, 51, 55, 57, 61, 62, 63, 66, 77, 79, 80
Multiplex PCR 4 27, 43, 51, 55
Fingerprinting10 13 20, 24, 31, 33–36, 41, 43, 47, 52, 55, 74
Hybridisation11 5 22, 25, 32, 45, 46
TOTAL 78
Main topic
of research2
Clustering of VMB 17 24, 28, 31, 35, 36, 40, 42, 48, 50, 56, 58, 60, 62, 65, 71, 72, 79
Improving BV diagnosis 5 30, 47, 76, 79, 80
Descriptive – other12 27 18, 21, 24, 28, 33, 35, 38, 39, 42, 48, 51, 54–56, 59, 60, 62, 63, 66, 68–70, 72, 73, 77–
79
Longitudinal VMB changes 20 18, 21, 23, 25, 26, 33, 38, 39, 42, 49, 54, 56, 59, 62, 63, 66, 67, 69, 77, 78
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Nugent score of 7–10 (20 articles), with an additional nine using a
Nugent score of 7–10 plus the presence of three or more Amsel
criteria, and the remaining eight using a variety of other definitions
based on microscopy and clinical symptoms.
Vaginal bacterial communities by clustering
The 17 studies that used a clustering technique to characterize
the composition of VMB bacterial communities can be subdivided
into those that used comprehensive data based on next generation
sequencing of DNA extracted from vaginal samples (10 articles)
[36,40,42,48,56,58,60,65,71,72] and those that used less compre-
hensive data by sequencing DNA of bacterial culture colonies (2)
[28,50], fingerprinting (3) [24,31,35], or qPCR (2) [62,79]
(Table 2). The articles included different study populations and
employed a variety of molecular and clustering procedures, but
consistent clustering patterns can be discerned nonetheless. A total
of three to nine clusters were described. The majority of studies
found one cluster dominated by L. iners (15 articles) and one
dominated by L. crispatus (11) (Table 2). Clusters dominated by L.
jensenii (2 articles), L. gasseri (5), or G. vaginalis (4) were less
common. Clusters containing high proportions of multiple
Lactobacillus spp., or Lactobacillus spp. combined with G.
vaginalis, were described in eight articles.
All studies identified at least one cluster that was not dominated
by a single taxon, but contained mixtures of anaerobes with or
without Lactobacillus spp. (Table 2). These clusters typically
contained L. iners (sometimes L. gasseri) and G. vaginalis, plus
mixtures of other strict or facultative anaerobic bacteria. In the ten
studies that employed next generation sequencing of DNA
extracted from vaginal samples, the 25 most abundant taxa
consistently (in at least 50% of studies) included the following
additional taxa: A. vaginae, Eggerthella spp., Mobiluncus spp.,
Lachnospiraceae (including the species BVAB1-3), Dialister spp.,
Megasphaera spp., Parvimonas (formerly Peptostreptococcus) spp.,
Veillonella spp., Streptococcus spp., Staphylococcus spp., Gemella
spp., Prevotella spp., Porphyromonas spp., Bacteroides spp.,
Sneathia spp., Leptotrichia spp., Mycoplasma spp., Ureaplasma
spp., and Escherichia/Shigella spp. Other bacterial taxa were often
found but either in low abundance or not consistently. Most
articles identified more than one cluster with mixed taxa; these
clusters typically did not differ significantly in the total number or
types of bacterial taxa present but they did differ in their relative
proportions. We were not able to discern consistent patterns across
studies. Only three of the 17 articles reported clusters dominated
by streptococci, staphylococci, Proteus spp., or Escherichia/
Shigella spp. (Table 2).
Longitudinal VMB patterns
One of the conclusions of the Human Microbiome Project was
that within-subject microbiota variation over time was lower than
between-subject variation for all habitats, including the vagina
[67]. Similarly, several longitudinal VMB studies showed that a
majority of women have a stable VMB microbiome
[23,26,54,59,62]. A study in post-menopausal women showed
that the VMB is usually stable in that group as well [49]. However,
while one study suggests that an increased VMB diversity is
Table 1. Cont.
Number of
articles References
Extravaginal reservoirs13 6 34, 43, 47, 55, 56, 61
VMB associations with HIV 11 20, 30, 40, 44, 45, 46, 48, 51, 53, 58, 77
VMB associations with HPV 5 46, 56, 66, 71, 74
VMB associations with other STIs 4 51, 64, 72, 79
VMB associations with other
infections14
5 27, 32, 47, 65
VMB associations with non-
infectious reproductive health
outcomes
4 32, 49, 69, 78
VMB associations with immune
activation
1 22
TOTAL 105
BV=bacterial vaginosis; DGGE =Denaturing Gradient Gel Electrophoresis; HIV = human immunodeficiency virus; HPV =human papillomavirus; IVF = in-vitro fertilisation;
LH-PCR = Length Heterogeneity PCR; NGS = next generation sequencing; qPCR =quantitative polymerase chain reaction; Randomly Amplified Polymorphic DNA (RAPD);
STD clinic = sexually transmitted disease clinic; STI = sexually transmitted infection; TRLFP = Terminal Restriction Fragment Length Polymorphism; USA =United States of
America; VMB= vaginal microbiota; WSW=women having sex with women.
1Until 15 November 20131;
2One article could include more than one category;
3Europe other: Sweden (4), Greenland (1), Estonia (1), Austria (1);
4Asia other: Japan (2), South Korea (1);
5East Africa: Kenya (3), Tanzania (1);
6West Africa: Burkina Faso (1), Ghana, Togo, Guinea and Mali (1);
7Central America: Mexico (2), Costa Rica (1);
85 publications representing only 3 studies;
9Genes sequenced: 16S rRNA gene V1–V2 (8), V2–V3 (2), V3 (2), V3–V5 (3), V4–V6 (2), V6 (2), V6–V9 (1), chaperonin gene (1), and not reported (1);
10Fingerprinting techniques used: TRFLP (5), DGGE (5), RAPD (2), and LH-PCR (1);
11Hybridisation techniques used: DNA microarray (4) and Luminex (oligonucleotides coupled to beads; 1);
12Descriptive other includes effects of race/ethnicity, pregnancy, menstrual cycle, menopause, tampon/pad use, vaginal douching, sexual debut and other sexual and
contraceptive behaviours;
13Cervical or endometrial microbiota (3) and oral and/or rectal reservoirs (3);
14Other confirmed infections: Candidiasis (2), cervicitis (1), endometritis (1), and gingivitis (1).
doi:10.1371/journal.pone.0105998.t001
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associated with a decreased stability [23], others suggest that this is
not necessarily the case: for example, a BV-associated VMB can
be stable and persist for a long time [59]. The few articles that
describe VMB transitions in molecular detail agree that women
who have a L. crispatus-dominated VMB at baseline are less likely
to transition to a BV-associated VMB than women who have a L.
iners-dominated VMB [33,30,59]. The study that evaluated VMB
transitions in the greatest detail found that a L. crispatus VMB
more often transitions to a L. iners-dominated or mixed
lactobacilli VMB than to a BV-associated VMB, and that a L.
iners-dominated VMB compared to a L. crispatus-dominated
VMB is twice as likely to transition to a BV-associated VMB [59].
Data on transitions related to L. jensenii, L. gasseri, and L.
vaginalis-dominated VMBs are rare [33,59]. One study in women
who had clinical BV showed that BV is more likely to be persistent
when BVAB1-3, Peptoniphilus lacrimalis, or Megasphaera type 2
are present in the VMB [21].
Extravaginal reservoirs of VMB bacteria
The Human Microbiome Project also concluded that vaginal
microbial communities are relatively ‘simple’ at genus-level
compared to oral and gut communities, but have a higher
diversity of Lactobacillus spp. [67]. Solt et al. identified 673 genera
in the rectum, 275 in the mouth, and 112 in the vagina [81].
Three studies assessed the presence of lactobacilli and other VMB
taxa in rectal and oral specimens, as well as vaginal specimens, to
test the hypothesis that the gut and mouth act as extravaginal
reservoirs of VMB bacteria [34,55,61]. Lactobacilli and various
BV-associated bacteria were indeed often found in the rectum,
while lactobacilli were sometimes, and G. vaginalis consistently,
found in the mouth. In one study, women who had high quantities
of G. vaginalis in the mouth or rectum, or Megasphaera,
Leptotrichia, or Sneathia spp. in the rectum, were more likely to
develop clinical BV during follow-up; in contrast, women who had
L. crispatus in the rectum were less likely to develop clinical BV
[61].
VMB associations with traditional BV diagnostics
More than half of the articles (37) described molecular VMB
data in relation to BV diagnosis by Amsel and/or Nugent criteria
[19–23,25–27,30,32,33,37,38,40–42,45,47,48,50–
54,56,59,60,62,63,65,67,72,73,75,76,79,80]. Two important areas
of consensus emerged. First, almost all women carry vaginal
lactobacilli regardless of their BV status by Nugent or Amsel
criteria [19,20,22,23,25,26,33,37–
42,45,47,48,54,59,60,62,63,73,76,80] but L. crispatus is predom-
inantly found in BV-negative women
[20,22,23,25,32,33,37,38,40,42,48,50,54,59,60,62,63,65,73,75,76-
,80] whereas L. iners (and to a lesser extent L. gasseri) is also found
in women with intermediate microbiota or BV
[21,23,25,33,37,38,40–42,47,50,54,59,60,62,63,65,73,76,79,80].
This is also reflected in correlation studies, in which L. iners
correlates well with BV-associated bacteria but not with L.
crispatus [56,65]. A second area of consensus is that BV diagnosis
is characterized by increased bacterial diversity and the presence
of the multiple taxa of (facultative) anaerobes that were described
in the previous paragraph [19–23,25–27,30,32,33,37,38,40–
42,45,47,48,50–54,56,59,60,62,63,65,67,72,73,75,76,79,80].
qPCR studies consistently report a decline in overall Lactobacillus
load in BV, and an increase in bacterial loads of BV-associated
Table 2. Vaginal microbiota communities identified by clustering techniques in 17 articles.
Cluster Molecular techniques1 References Total
Dominated by Lactobacillus crispatus All except qPCR2 24, 31, 35, 36, 40, 42, 50,
56, 65, 71, 72
11
Dominated by L. iners All 24, 31, 35, 36, 40, 42, 48,
50, 56, 58, 60, 65, 71, 72, 79
15
Dominated by L. jensenii Direct sequencing
and fingerprinting
35, 42 2
Dominated by L. gasseri Direct sequencing and fingerprinting 31, 35, 36, 42, 56 5
Dominated by lactobacilli
but unspecified
Sequencing of culture colonies 28 1
Dominated by lactobacilli
but multiple species
All 24, 35, 60, 62, 65 5
Dominated by Gardnerella vaginalis Direct sequencing and qPCR 40, 48, 56, 79 4
Mixture of lactobacilli
and G. vaginalis
Direct sequencing and
sequencing of culture colonies
28, 40, 56 3
Mixture of lactobacilli, G. vaginalis
and other anaerobes3
All except qPCR 28, 31, 42, 48, 56, 58, 60, 65 8
Mixed anaerobes3 with
few/no lactobacilli
All 24, 28, 35, 36, 40, 50,
56, 58, 60, 62, 71, 72, 79
13
Dominated by aerobes4 Direct sequencing and fingerprinting 35, 58, 65 3
qPCR =quantitative polymerase chain reaction.
1Includes direct sequencing (next generation sequencing) of DNA extracted from vaginal samples (10), sequencing of culture colonies (2), fingerprinting (3), and qPCR
(2); the 5 studies using DNA hybridisation techniques did not employ data clustering and this technique is therefore not represented in this table.
2One qPCR study only assessed L. iners and the other qPCR study did not find clusters dominated by just one Lactobacillus species.
3Other than Lactobacillus spp., the 25 most abundant taxa in the 10 direct sequencing studies consistently (in at least 50% of studies) include: Phylum Actinobacteria: G.
vaginalis, A. vaginae, Eggerthella spp., Mobiluncus spp.; Phylum Fermicutes: Lachnospiraceae (including BVAB1-3), Dialister spp., Megasphaera spp., Parvimonas (formerly
Peptostreptococcus) spp., Veillonella spp., Streptococcus spp., Staphylococcus, spp., Gemella spp.; Phylum Sfingobacteria: Prevotella spp., Porphyromonas spp., Bacteroides
spp.; Phylum Fusobacteria: Sneathia spp., Leptotrichia spp.; Phylum Tenericutes: Mycoplasma spp., Ureaplasma spp.; Phylum Proteobacteria: Escherichia/Shigella spp.
4Includes Streptococcus spp., Staphylococcus spp., Escherichia/Shigella spp., Proteus spp.
doi:10.1371/journal.pone.0105998.t002
Molecular Characterization of Vaginal Microbiome
PLOS ONE | www.plosone.org 5 August 2014 | Volume 9 | Issue 8 | e105998
bacteria [26,41,47,62,76,80]. It is not yet clear from the studies we
reviewed whether BV is associated with a higher overall bacterial
load than healthy lactobacilli-dominated microbiota. Importantly,
several studies showed that G. vaginalis and Prevotella spp. are
often found regardless of BV status by Nugent or Amsel criteria,
but their abundances increase in BV; furthermore, a synergistic
effect between them was noted [26,37,41,42,62,79]. The role of
streptococci, staphylococci, and enterococci is generally not well
described; when present, they are usually present in low
abundance. One study (using DNA hybridization) reported that
their presence in the VMB did not differ by BV status [32],
whereas another study (also using DNA hybridization) reported
higher levels in women with intermediate microbiota by Nugent
score [22].
Higher bacterial diversity and/or higher levels of individual BV-
associated bacteria are consistently associated with a higher
vaginal pH [30,42,60,67,72,80] and Nugent score [42,47,51,80].
Vice versa, increasing abundance of lactobacilli is consistently
associated with a lower vaginal pH [30,40,67,80] and Nugent
score [80]. Associations with the other Amsel criteria have been
less well studied, but one study found that only the Leptotrichia
and Eggerthella genera were associated with all four Amsel criteria
[60].
VMB associations with other clinical outcomes
Vaginal colonization with Candida spp. seems more common in
women with a lactobacilli-dominated VMB than in women with
BV [26,31,72], as had been noted previously in epidemiological
studies using traditional diagnostic methods [11]. In contrast, T.
vaginalis has often been strongly associated with BV in the past,
and this was confirmed in a study using 454 sequencing [64].
Convincing patterns of associations between bacterial sexually
transmitted infections (STIs) and the molecular composition of the
VMB did not emerge, most likely due to the fact that women with
bacterial STIs were often excluded or the prevalence rates were
low.
Eleven studies assessed the VMB by HIV status [20,30,40,44–
46,48,51,53,58,77] and five studies by HPV status
[46,56,66,71,74]. One study found no relationship between HIV
and the VMB [53], but most found trends towards decreased
lactobacilli (and particularly L. crispatus) [44,46,48] and increased
bacterial diversity [45,51], particularly in women who had both
HIV as well as BV by Nugent score [20]. Similar trends were
found related to HIV-1 RNA load in the genital tract [30,77]. One
study found an increased prevalence of E. coli-dominated VMB in
HIV-positive women [48], and another one found increased HIV
transmission from mother to child with increasing VMB diversity
in the mother (although this did not reach statistical significance)
[58]. HPV also seems to be associated with a reduction in
lactobacilli [71] and increased VMB diversity [46,71,74]. In one
study, Sneathia spp. were strongly associated with the presence of
high risk HPV [71].
The cervical microbiota are similar to the VMB, except that
bacterial loads are lower [47]. A comprehensive qPCR study
showed that cervical bacterial diversity is highest in women with
BV, followed by women with cervicitis and healthy women, with
only small differences between the latter two; BV was associated
with a dramatic reduction in lactobacilli in the vagina and cervix,
whereas cervicitis with a reduction in the cervix only [47]. The
authors conclude that the VMB does not play a large role in
cervicitis. Another study found good agreement between PCR
results of five BV-associated species in cervical and endometrial
samples of women with pelvic inflammatory disease, although this
did not reach statistical significance [27].
BV and gingivitis were also reported to be associated, with
counts of P. bivia, P. disiens, M. curtisii, and M. mulieris being
particularly high in women with both BV and gingivitis [32].
Finally, a lactobacilli-dominated VMB was associated with a
reduced risk of pre-term birth, a higher likelihood of IVF resulting
in a live birth, and a reduced risk of vaginal dryness in
postmenopausal women in one study each [49,69,78].
We found only one study that correlated molecular VMB
composition (using both culture and a DNA-DNA checkerboard
including L. iners and 12 BV-associated species) with vaginal
immune responses [22]. Total viable bacterial counts and the
presence of BV-associated bacteria were positively associated with
cervicovaginal IL-1a and IL-1b (and BV-associated bacteria also
with IL-6 and IL-8), whereas L. iners was negatively associated
with IL-1a. The relationships with secretory leukocyte protease
inhibitor (SLPI) were the other way around.
VMB associations with demographic and behavioral
characteristics
Data on the association between the molecular VMB and age
were inconsistent. Six studies did not find an association but four
of these only included a narrow age range (exclusively reproduc-
tive age or post-menopausal women) [42,49,62,72]; one study did
not find a difference between reproductive age and post-
menopausal women [76] and another one did not find a difference
between adolescents and women of reproductive age [24].
However, three studies that quantified multiple Lactobacillus
spp. found lower overall levels, as well as reduced L. crispatus
levels and Lactobacillus diversity, in post-menopausal women
compared to women of reproductive age [43,55,57].
Several articles report that Black African and African-American
women compared to Caucasian or Asian women are less likely to
carry L. crispatus, L. jensenii, L. gasseri and/or L. vaginalis and
more likely to carry L. iners, and are more likely to have a higher
bacterial diversity [35,42,60,62,77,78]. One study found the same
for U.S. Hispanic women [42].
Few studies found significant associations between the VMB at
the molecular microbial level and sexual behavior. However,
detailed sexual behavior data were mostly not collected, sample
sizes were small, or analyses focused on risk factors for BV by
Amsel or Nugent criteria even though bacterial molecular data
were also available. One study found that the detection of
prostate-specific antigen (as a marker of sexual activity within the
last 48 hours) was negatively associated with L. crispatus and
positively with L. iners and L. gasseri [62]. In another study, the
prevalence of various BV-associated bacterial genera was in-
creased with an increasing number of sexual partners [51]. Finally,
a comprehensive study found a slight gain of G. vaginalis after
sexual debut, but no significant gain of other BV-associated
bacteria or loss of lactobacilli [66].
Even though most studies that evaluated the influence of the
menstrual cycle were small, they consistently suggest that high
levels of estradiol (assessed by phase in the menstrual cycle or in
serum of IVF patients) promote lactobacilli, and particularly L.
crispatus [18,59,69,70]. Studies also consistently suggest that
menses is the largest disturbing factor during the menstrual cycle,
with sometimes large reductions in lactobacilli [38,59,62,63], shifts
from L. crispatus to L. iners [38,70], or the appearance of BV-
associated bacteria, streptococci or other Gram-positive cocci
[54,70]. Pregnancy, which is also accompanied by high estradiol
levels, is associated with high levels of lactobacilli, particularly L.
crispatus, and low bacterial diversity [55,68]. However, one study
found an increasing bacterial diversity in late term pregnancies
[68]. In another study, a VMB dominated by L. iners or L. gasseri
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in the first trimester was more likely to evolve to BV later on
during pregnancy; L. crispatus had the opposite effect [33].
Discussion
Despite the fact that many different molecular techniques and
operating procedures with specific advantages and disadvantages
have been used (reviewed in [14]) and despite the fact that these
technical differences can result in under- or overrepresentation of
bacterial species [82], we found several areas of consensus about
the VMB composition. Studies have now conclusively shown that
lactobacilli-dominated VMB are associated with a healthy vaginal
micro-environment, and that BV is best described as a poly-
bacterial dysbiosis: the Lactobacillus load decreases, and both the
diversity and bacterial load of other (facultative) anaerobic bacteria
increase [24,28,31,35,36,40,42,48,50,56,58,60,62,65,71,72,79].
Furthermore, the bacteria associated with this dysbiosis are now
well described
[24,28,31,35,36,40,42,48,50,56,58,60,62,65,71,72,79]. Some are
consistently found (G. vaginalis, A. vaginae, bacteria in the
Lachnospiraceae family (including BVAB1-3), and species in the
following genera: Prevotella, Eggerthella, Dialister, Megasphaera,
Sneathia, Leptotrichia, Parvimonas (formerly Peptostreptococcus),
Veillonella, Bacteroides, Mobiluncus, Porphyromonas, Mycoplas-
ma, Ureaplasma, Streptococcus, Staphylococcus, Gemella, and
Escherichia/Shigella) whereas others are not consistently found
but can be part of a long tail of minority species. G. vaginalis and
Prevotella spp. are also often present in healthy women, but their
bacterial loads increase significantly in dysbiosis. Consensus is also
emerging about the relative importance of different Lactobacillus
species: L. iners is present in almost all women worldwide
including those with dysbiosis; L. crispatus is mostly present in
healthy women and might be less common in women of African or
Hispanic descent; and L. jensenii, L. gasseri, and L. vaginalis are
much less common
[24,28,31,35,36,40,42,48,50,56,58,60,62,65,71,72,79]. Further-
more, longitudinal studies have shown that a L. crispatus-
dominated VMB might transition to a L. iners-dominated VMB
but is less likely to transition directly to a dysbiotic state (and vice
versa) [33,59]. The gut, and to a lesser extent the mouth, serve as
extravaginal reservoirs of common VMB bacteria [34,55,61].
An increase of bacterial diversity and BV-associated bacteria is
consistently associated with an increase in Nugent score and/or
vaginal pH, but not with the other three Amsel criteria
[30,42,47,51,60,67,72,80]. This is reassuring because our current
knowledge about the epidemiology of vaginal dysbiosis is mostly
based on Nugent scoring. A recent study by Srinivasan and
colleagues, however, questioned the microbial interpretation of
Nugent scoring [83]. This study showed that the Mobiluncus
morphotype more likely represents BVAB-1 than Mobiluncus spp.,
and the Bacteroides morphotype more likely represents Porphyr-
omonas and Prevotella spp than Bacteroides spp. While these are
important observations, the clinical relevance is unclear because
all of these bacterial species are associated with vaginal dysbiosis.
The composition and significance of the intermediate Nugent
category remains unclear. One molecular study suggested that this
category is a transition state from a lactobacilli-dominated VMB to
dysbiosis or vice versa [40], but another study found an association
with VMB clusters dominated by the facultative anaerobic
bacteria that have been implicated in aerobic vaginitis [4,22].
While it is important to investigate this further to allow for the
proper interpretation of epidemiological studies that have used/
are using Nugent scoring to characterize the VMB, it is likely that
future studies will replace Nugent scoring by molecular VMB
characterization and quantification.
We found much less consensus on VMB associations with
sociodemographic, behavioral, and clinical characteristics, mostly
because few studies were designed to evaluate these. Three areas
of consensus stood out: Vaginal colonization with Candida spp.
was consistently more common in women with a lactobacilli-
dominated VMB than women with bacterial dysbiosis [26,31,72],
infection with Trichomonas vaginalis is associated with vaginal
dysbiosis [64], and a high level of estradiol is consistently
associated with lactobacilli [18,59,69,70]. The latter is also
supported by many studies that evaluated the VMB by microscopy
(reviewed in [84]). The data on the associations between the VMB
and HIV and HPV infection are not entirely consistent but also
point in the direction of decreased lactobacilli and increased
bacterial diversity when a STI is present. We recently confirmed
this in a study in women at high risk of HIV and other STIs in
Rwanda [85]. This study showed that women with L. crispatus-
dominated VMB had the lowest prevalence of HIV, HPV and
herpes simplex type 2 (and had no bacterial STIs), with a slight
increase in women with a L. iners-dominated VMB, and a
significant increase in women with vaginal dysbiosis. A similar
trend was found for HIV-1 RNA shedding in the genital tract of
HIV-positive women. Since the study was cross-sectional, the
temporality of these relationships remains to be elucidated.
It is worth emphasizing that the molecular studies did not
identify large VMB differences between adolescent, reproductive
age, and post-menopausal women [24,79], except in post-
menopausal women with vaginal atrophy and dryness [49]. Post-
menopausal women have lower estrogen levels, which might lead
to less protection from dysbiosis. However, they no longer
menstruate, and are therefore protected from the potentially
negative effects of menstrual blood and increased vaginal pH on
the VMB.
Our review also highlighted many research gaps. Most
importantly, we still do not sufficiently understand how the
VMB is established and maintained, and how bacterial dysbiosis
develops and resolves. In particular, the roles of L. crispatus (which
seems to inhibit dysbiosis), L. iners (which does not seem to inhibit
dysbiosis), and G. vaginalis and Prevotella spp. (which are often
present in healthy women in low abundance but greatly increase in
abundance in the dysbiotic state) are not well understood. The role
of L. iners is particularly controversial [9,86,87]. L. iners is well
adapted to the vaginal niche, is present in many different types of
VMBs, and often persists after antibiotic treatment. This could
mean that L. iners easily tolerates the presence of other bacteria
(which in turn could lead to dysbiosis), or that it helps to restore a
lactobacilli-dominated VMB during and after dysbiosis and/or
antibiotic treatment. One appealing hypothesis regarding the
development of dysbiosis is the formation of a vaginal biofilm [88].
Current evidence suggests that G. vaginalis can be present in the
vagina as dispersed bacteria or as biofilm-associated (cohesive)
bacteria, with the former associated with a lower total bacterial
load than the latter [89]. In-vitro studies suggest that when the
concentration of G. vaginalis increases, it starts to adhere to the
vaginal epithelium, providing a scaffolding to which other species
adhere [90]. Initial human biopsy studies focused on A. vaginae as
another potentially important biofilm member [91], and one study
found that L. iners increases G. vaginalis adherence in-vitro
(although this did not reach statistical significance) [92]. However,
more research is needed to properly evaluate the potential role of
all relevant lactobacilli and dysbiosis-associated bacteria in biofilm
formation. Furthermore, it is not yet entirely clear whether the
dispersed and cohesive forms of G. vaginalis represent different G.
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vaginalis strains. Recent studies revealed that different G.
vaginalis strains have different metabolic and virulence properties
[93], encode different types of biofilm-associated proteins [94],
and behave differently in in-vitro biofilm experiments [95]. The
biofilm hypothesis might explain the high persistence and
recurrence rates of dysbiosis because bacteria in the biofilm are
dormant and therefore less susceptible to antibiotics [88]. In
addition, the extracellular matrix surrounding the bacteria in the
biofilm inhibits penetration of lactic acid, natural antimicrobial
compounds, and antibiotics [88]. However, other explanations,
such as reinfection by sexual partners and spore formation, might
also play a role [21]. The biofilm hypothesis might also explain
why Candida spp. more commonly overgrow when only dispersed
bacteria are present and epithelial cells are exposed: Candida
needs to attach to epithelial cells to thrive in the vagina [96].
Whether bacterial dysbiosis is symptomatic or not most likely
depends on the degree and nature of the dysbiosis, bacterial loads,
type and quantity of virulence factors expressed by bacteria, and
the intensity and nature of the host’s immune responses [97].
‘Thresholds’ (in terms of bacterial loads and diversity) might exist.
While most of the above-mentioned dysbiosis-associated bacteria
are never pathogenic in immune-competent hosts, streptococci,
staphylococci and E. coli can cause invasive disease when present
in sufficiently high abundance. S. agalactiae has been particularly
well studied in that regard, and studies have indeed shown that the
greater the density of colonization, the greater the probability of
invasive disease in postpartum women and their neonates [98].
Only three molecular studies included in our review reported
VMB clusters dominated by streptococci, staphylococci, and/or E.
coli [35,58,65] but many additional studies showed presence of
these bacteria in low abundance; this is in agreement with studies
using selective culture media [7]. In-vitro studies confirm that S.
agalactiae only inhibits growth of other bacteria at concentrations
higher than 109 colony forming units per ml (but does not inhibit
S. aureus and E. coli), and such high concentrations are rarely
seen in vivo [98]. If aerobic vaginitis is defined as a VMB
composition dominated by these bacteria, we conclude that it does
exist but is not common. Future studies of invasive infections by
streptococci, staphylococci, and E. coli should determine vaginal
concentrations and not just vaginal presence.
We also do not yet sufficiently understand the metabolic
synergies and dependencies of the various bacterial communities
that are commonly found in the vagina. Recent studies have
focused on L. iners, which is present in almost all women
worldwide, in healthy and dysbiotic states. These studies suggest
that L. iners is highly adapted to the vaginal compartment [9,86],
but it differentially expresses over 10% of its genome in dysbiotic
compared to healthy states, with increased expression of a
cytolysin, mucin, glycerol transport and related metabolic enzymes
[87]. These changes likely result in the production of succinate and
other short-chain fatty acids as the end product of metabolism as
opposed to lactic acid, leading to an increased vaginal pH. L. iners
might also be the first Lactobacillus species to recover after
dysbiosis [59], which suggests a bidirectional relationship between
L. iners and vaginal pathogens or dysbiosis. Other studies have
noted synergistic effects between G. vaginalis and Prevotella spp.,
perhaps due to metabolic dependencies [91,98]. At the moment,
metagenomic studies of vaginal bacteria are ongoing but difficult
to conduct because the public sequence databases do not yet
contain all relevant bacterial genomes.
While molecular techniques have significantly improved our
understanding of the VMB, some limitations should be noted.
Molecular techniques detect viable as well as non-viable organ-
isms, some cannot reliably differentiate species within a genus,
some cannot adequately detect minority species, and most are not
fully quantitative. We have taken this into account in our data
interpretations as much as possible. Furthermore, even when the
same molecular techniques were used, different laboratories used
different operating procedures. Not all of these are important, but
some (such as DNA extraction methods, amplification platform,
choice of amplification target or of variable 16S region, choice or
design of primers, and the presence or absence of proper negative
controls to detect contamination) might result in significant inter-
laboratory variation [14]. We were fully aware of these limitations
and therefore focused this review on areas of consensus.
Now that the VMB of women with and without dysbiosis in
different parts of the world have been well described, and
molecular techniques have become more accessible and afford-
able, we believe that the time has come to incorporate these
techniques into larger epidemiological studies with clinical
outcomes. These studies should investigate the etiology and
pathogenesis research gaps that were outlined above, but also
possible transmission patterns of VMB bacteria, and the temporal
relationships between the VMB and adverse reproductive health
outcomes, such as HIV/STIs, pelvic inflammatory disease,
adverse pregnancy outcomes, and invasive infections in preg-
nant/postpartum women and their neonates. At the moment,
most treatment guidelines only advise clinicians to treat symp-
tomatic vaginal dysbiosis, but this might have to be re-evaluated in
specific at risk population groups (such as pregnant women or
women highly exposed to HIV) if dysbiosis is identified as a strong
risk factor for adverse outcomes in sufficiently powered longitu-
dinal studies. In parallel, interventions that prevent dysbiosis,
disrupt biofilms, and restore and maintain lactobacilli-dominated
microbiota, should continue to be optimized and tested. The VMB
studies discussed in this review have provided us with the tools to
properly evaluate the safety and efficacy of such interventions. If
safe, efficacious and affordable interventions are identified, they
could potentially have a significant public health impact.
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